FDA Inspection
McGuff Pharmaceuticals, Inc.McGuff Pharmaceuticals, Inc. – FDA Inspection, Aug 20, 2024
Record Details
This FDA Inspection record concerns McGuff Pharmaceuticals, Inc., with an inspection on August 20, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 65b55a0b-b9f3-46d2-8f5d-7c4d9be18a59
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1229677
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of McGuff Pharmaceuticals, Inc.
12| Date | Classification | Office | Project area |
|---|---|---|---|
| April 28, 2025 | OAI | Los Angeles District Office | Drug Quality Assurance |
| January 26, 2024 | VAI | Los Angeles District Office | New Drug Evaluation |
| November 22, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 26, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 2, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for McGuff Pharmaceuticals, Inc.
- FDA Inspection 1268175 - 2025-04-28
- FDA Inspection 1228033 - 2024-01-26
- FDA Inspection 1110847 - 2019-11-22
- FDA Inspection 1083919 - 2019-03-26
- FDA Inspection 1013240 - 2017-06-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.